sumatriptan has been researched along with Retinal Artery Occlusion in 1 studies
Sumatriptan: A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.
sumatriptan : A sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). Used (in the form of its succinate salt) for the acute treatment of migraine with or without aura in adults.
Retinal Artery Occlusion: Sudden ISCHEMIA in the RETINA due to blocked blood flow through the CENTRAL RETINAL ARTERY or its branches leading to sudden complete or partial loss of vision, respectively, in the eye.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Srienc, AI | 1 |
| Biesecker, KR | 1 |
| Shimoda, AM | 1 |
| Kur, J | 1 |
| Newman, EA | 1 |
1 other study available for sumatriptan and Retinal Artery Occlusion
| Article | Year |
|---|---|
Ischemia-induced spreading depolarization in the retina.
Topics: Animals; Brain Ischemia; Cortical Spreading Depression; Dizocilpine Maleate; Excitatory Amino Acid A | 2016 |